A novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-35

Abstract Organ transplantation remains the most effective treatment for patients with late stage organ failure. Transgenic pigs provide an alternative organ donor source to the limited availability of human organs. However, cellular rejection still remains to be the obstacle for xenotransplantation....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mingqian Li, Judith Eckl, Christiane Geiger, Dolores J. Schendel, Heike Pohla
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7fbf1c589ce943f3a4e6124b4af9f078
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7fbf1c589ce943f3a4e6124b4af9f078
record_format dspace
spelling oai:doaj.org-article:7fbf1c589ce943f3a4e6124b4af9f0782021-12-02T12:30:13ZA novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-3510.1038/s41598-017-04322-32045-2322https://doaj.org/article/7fbf1c589ce943f3a4e6124b4af9f0782017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04322-3https://doaj.org/toc/2045-2322Abstract Organ transplantation remains the most effective treatment for patients with late stage organ failure. Transgenic pigs provide an alternative organ donor source to the limited availability of human organs. However, cellular rejection still remains to be the obstacle for xenotransplantation. Superior to other methods, antigen-specific regulatory T cells (Treg) alleviate cellular rejection with fewer side effects. Here we demonstrate the use of a fast method to provide tolerogenic dendritic cells (tolDC) that can be used to generate effective porcine-specific Treg cells (PSTreg). TolDC were produced within three days from human monocytes in medium supplemented with anti-inflammatory cytokines. Treg were generated from naïve CD4+ T cells and induced to become PSTreg by cocultivation with porcine-antigen-loaded tolDC. Results showed that PSTreg exhibited the expected phenotype, CD4+CD25+CD127low/− Foxp3+, and a more activated phenotype. The specificity of PSTreg was demonstrated by suppression of effector T cell (Teff) activation markers of different stages and inhibition of Teff cell proliferation. TolDC and PSTreg exhibited high expression of IL-10 and TGF-β1 at both protein and RNA levels, and PSTreg also highly expressed IL-35 at RNA levels. Upon restimulation, PSTreg retained the activated phenotype and specificity. Taken together, the newly developed procedure allows efficient generation of highly suppressive PSTreg.Mingqian LiJudith EcklChristiane GeigerDolores J. SchendelHeike PohlaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Mingqian Li
Judith Eckl
Christiane Geiger
Dolores J. Schendel
Heike Pohla
A novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-35
description Abstract Organ transplantation remains the most effective treatment for patients with late stage organ failure. Transgenic pigs provide an alternative organ donor source to the limited availability of human organs. However, cellular rejection still remains to be the obstacle for xenotransplantation. Superior to other methods, antigen-specific regulatory T cells (Treg) alleviate cellular rejection with fewer side effects. Here we demonstrate the use of a fast method to provide tolerogenic dendritic cells (tolDC) that can be used to generate effective porcine-specific Treg cells (PSTreg). TolDC were produced within three days from human monocytes in medium supplemented with anti-inflammatory cytokines. Treg were generated from naïve CD4+ T cells and induced to become PSTreg by cocultivation with porcine-antigen-loaded tolDC. Results showed that PSTreg exhibited the expected phenotype, CD4+CD25+CD127low/− Foxp3+, and a more activated phenotype. The specificity of PSTreg was demonstrated by suppression of effector T cell (Teff) activation markers of different stages and inhibition of Teff cell proliferation. TolDC and PSTreg exhibited high expression of IL-10 and TGF-β1 at both protein and RNA levels, and PSTreg also highly expressed IL-35 at RNA levels. Upon restimulation, PSTreg retained the activated phenotype and specificity. Taken together, the newly developed procedure allows efficient generation of highly suppressive PSTreg.
format article
author Mingqian Li
Judith Eckl
Christiane Geiger
Dolores J. Schendel
Heike Pohla
author_facet Mingqian Li
Judith Eckl
Christiane Geiger
Dolores J. Schendel
Heike Pohla
author_sort Mingqian Li
title A novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-35
title_short A novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-35
title_full A novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-35
title_fullStr A novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-35
title_full_unstemmed A novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-35
title_sort novel and effective method to generate human porcine-specific regulatory t cells with high expression of il-10, tgf-β1 and il-35
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/7fbf1c589ce943f3a4e6124b4af9f078
work_keys_str_mv AT mingqianli anovelandeffectivemethodtogeneratehumanporcinespecificregulatorytcellswithhighexpressionofil10tgfb1andil35
AT juditheckl anovelandeffectivemethodtogeneratehumanporcinespecificregulatorytcellswithhighexpressionofil10tgfb1andil35
AT christianegeiger anovelandeffectivemethodtogeneratehumanporcinespecificregulatorytcellswithhighexpressionofil10tgfb1andil35
AT doloresjschendel anovelandeffectivemethodtogeneratehumanporcinespecificregulatorytcellswithhighexpressionofil10tgfb1andil35
AT heikepohla anovelandeffectivemethodtogeneratehumanporcinespecificregulatorytcellswithhighexpressionofil10tgfb1andil35
AT mingqianli novelandeffectivemethodtogeneratehumanporcinespecificregulatorytcellswithhighexpressionofil10tgfb1andil35
AT juditheckl novelandeffectivemethodtogeneratehumanporcinespecificregulatorytcellswithhighexpressionofil10tgfb1andil35
AT christianegeiger novelandeffectivemethodtogeneratehumanporcinespecificregulatorytcellswithhighexpressionofil10tgfb1andil35
AT doloresjschendel novelandeffectivemethodtogeneratehumanporcinespecificregulatorytcellswithhighexpressionofil10tgfb1andil35
AT heikepohla novelandeffectivemethodtogeneratehumanporcinespecificregulatorytcellswithhighexpressionofil10tgfb1andil35
_version_ 1718394405610586112